Altogether, these data suggest that survivin expression in aggressive SCC may provide a strong growth advantage factor for tumour progression, affording both protection from broad apoptosis-inducing stimuli/drugs and maintaining proper mitotic progression of the proliferating population. This evidence concerns the gene BIRC5 and neoplasm.